EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.

Translated title of the contribution: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.

J.S. Smolen, R. Landewé, F.C. Breedveld, M. Dougados, P. Emery, C. Gaujoux-Viala, S. Gorter, R. Knevel, J. Nam, M. Schoels, D. Aletaha, M. Buch, L. Gossec, T.W. Huizinga, J.W.J. Bijlsma, G. Burmester, B. combe, M. Cutolo, C. Gabay, J. Gomez-ReinoM. Kouloumas, T.K. Kvien, E. Martin-Mola, I. McInnes, K. Pavelka, P. Riel, M. Scholte, D.L. Scott, T. Sokka, G. Valesini, R. van Vollenhoven, K.L. Winthrop, J. Wong, A. Zink, D. van der Heijde

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.
Original languageUndefined/Unknown
Pages (from-to)964-975
Number of pages12
JournalAnnals of the Rheumatic Diseases
Volume69
Issue number6
Publication statusPublished - 2010

Cite this